Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 26  •  11:00AM ET
45.80
Dollar change
+0.58
Percentage change
1.28
%
Category
US Equities - Industry Sector
Asset Type
Equities (Stocks)
Tags
Return% 1Y
33.90%
Total Holdings
50
Perf Week
3.08%
Sponsor
REX Shares
ETF Type
Tags
Return% 3Y
-
AUM
697.61M
Perf Month
6.51%
Fund Family
Bond Type
Tags
Return% 5Y
-
NAV/sh
Perf Quarter
8.89%
Index
-
Average Maturity
Tags
Return% 10Y
52W High
49.68 -7.81%
Perf Half Y
4.11%
Index Weighting
Commodity Type
Tags
Return% SI
52W Low
37.90 20.84%
Perf YTD
0.55%
Active/Passive
Quant Type
Tags
Flows% 1M
4.57%
Volatility
1.45% 1.10%
Perf Year
5.90%
ESG Type
Tags
Flows% 3M
9.62%
ATR (14)
0.59
Perf 3Y
-
Dividend Type
Sector/Theme
Flows% YTD
15.99%
RSI (14)
71.57
Perf 5Y
-
Structure Type
Region
Flows% 1Y
Beta
1.02
Perf 10Y
-
Expense
0.65%
Growth/Value
SMA20
3.39%
Flows% 3Y
Rel Volume
3.13
Prev Close
45.22
Inverse/Leveraged
Market Cap
SMA50
7.41%
Flows% 5Y
Avg Volume
183.76K
Price
45.80
IPO
Oct 11, 2023
Option/Short
Yes / Yes
SMA200
2.16%
Trades
Volume
154,892
Change
1.28%
May-20-26 12:00PM
Jan-08-26 12:49PM
Oct-27-25 09:46AM
Jul-25-25 11:00AM
May-28-25 08:00AM
11:51AM Loading…
May-02-25 11:51AM
Apr-30-25 10:00AM
Apr-27-25 11:29PM
Apr-25-25 09:30AM
Apr-23-25 12:00PM
Mar-28-25 12:01PM
Mar-25-25 09:15AM
05:27AM
Dec-04-24 08:00AM
Jun-04-24 08:00AM
08:00AM Loading…
Oct-11-23 08:00AM
REX FANG & Innovation Equity Premium Income ETF seeks capital appreciation and current income. The fund is an actively managed exchange-traded fund ("ETF") that seeks current income while maintaining the opportunity for exposure to the share price (i.e., the price returns) of the securities of the companies comprising the Solactive FANG Innovation Index. The fund advisor seeks to employ the fund's investment strategy regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods.